NCT05313412 is a NA clinical trial of Lens A (comfilcon A lens) in Myopia, sponsored by CooperVision, Inc..

Who is sponsoring NCT05313412?

NCT05313412 is sponsored by CooperVision, Inc..

What drugs are being tested in NCT05313412?

Interventions in NCT05313412: Lens A (comfilcon A lens), Lens B (lehfilcon A lens).

Is NCT05313412 still recruiting?

NCT05313412 is currently completed. Last updated 9 May 2023.

Are results published for NCT05313412?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-05-09 · How we verify

NCT05313412

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Two Silicone Hydrogel Contact Lenses

Completed NA Results posted Last updated 9 May 2023

What this trial tests

NA trial testing Lens A (comfilcon A lens) in Myopia in 38 participants. Completed in 21 April 2022.

Timeline

27 January 2022

Primary endpoint
21 April 2022

21 April 2022

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	38
Start date	27 January 2022
Primary completion	21 April 2022
Estimated completion	21 April 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

Lens A (comfilcon A lens)
Lens B (lehfilcon A lens)

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

CooperVision, Inc.

Who can join

Adults 18 to 40, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Ease of Lens Insertion Primary · 6 hours

Ease of Lens Insertion is measured on a scale of 0-100 (0-Unmanageable, Lenses impossible to insert; 100-Excellent. No problems with lens insertion)

Group	Value	95% CI
Lens A	92.1	± 10.3
Lens B	90.9	± 17.4

Sponsor's own description

This study is to compare the short-term clinical performance and subjective acceptance of two silicone hydrogel soft contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lens A (comfilcon A lens)

Trials testing the same drug.

NCT05166902 — Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use · NA · completed
NCT05114564 — Evaluation of the Performance of Monthly Replacement Sphere Lens Designs in Habitual Soft Contact Lens Wearers · NA · completed

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other CooperVision, Inc. trials

Trials by the same sponsor.

NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05313412 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
Last refreshed: 9 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05313412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing